Four audiences. One shared, auditable basis for decisions.
01 / For patients & families
More understanding. Less uncertainty.
A future where treatment rationale, coverage questions, and expected costs are easier to understand—supporting informed conversations with the care team.
Current capability
Today, the benefit to patients is indirect: the care team working on their behalf has clearer evidence and clearer documentation.
↳Treatment recommendations the care team can trace to guideline sources.
↳Coverage documentation prepared with the supporting rationale attached.
↳Trial opportunities surfaced for review, with the open eligibility questions named.
A traceable basis for understanding treatment requests, recognizing missing information, and resolving disagreements.
↳Reviewer-facing tooling that shows the evidence behind a request, not just the request.
↳Shared decision records that reduce back-and-forth over missing information.
↳Measurable outcomes to support accountable care arrangements.
What this meansAccountability in every review.
04 / For technology partners
Shared evidence. Interoperable by design.
Guideline intelligence and trial matching that can be embedded in the systems care teams already use, with the rationale and its sources carried along.
Current capability
Capabilities that can be embedded in the systems care teams already use, with the rationale and its sources carried along.
↳Guideline queries with cited answers, embeddable in other clinical software.
↳Trial matching available through an interface for integration from your own systems.
↳An oncology EHR built as a system of record for practice workflows.